Former GSK CEO named Optum head
UnitedHealth Group has named its board member and former GlaxoSmithKline head Andrew Witty as chief executive of its pharmacy benefit unit, Optum, which manages drug benefits and offers healthcare data analytics services.
According to Optum, the unit's current CEO, Larry Renfro, will instead lead investment initiatives through Optum Ventures.
Witty's appointment will be effective July 1 with the former GSK head stepping down from the UnitedHealth Group board effective immediately.
Read the Reuters report